AHK-Cu
Last reviewed 2026-10-30
Our read Opinion
A published ex vivo/in vitro study supports a laboratory hair-growth hypothesis. Clinical effectiveness and injectable safety remain unestablished; US bulk-compounding eligibility was not verified.
- Type
- Cosmetic / supplement
- Regulatory status
- Cosmetic/research ingredient; no FDA-approved drug
- Compounding status
- Unclear / not listed
- FDA-approved indications
- None
- Evidence level
- In vitro / theoretical
- Routes studied
- Topical
- WADA
- Verify
- Developer
- —
Claims made by researchers, companies and users. Inclusion does not mean the claim is verified.
- —Claimed to support hair density and growth
An alanine-histidine-lysine copper complex studied for dermal papilla cell proliferation and hair-follicle elongation. Evidence comes from cultured cells and isolated human follicles, not clinical hair-regrowth trials.
AHK-Cu is investigated and marketed for cosmetic hair applications, not an FDA-approved hair-loss treatment. No EMA authorization was identified; injectable therapeutic authorization is unverified.
Statuses change; check the linked primary source.
Momentum Opinion
Watch
0 news items in last 30 days
Human tissue in a dish is not a human treatment trial. Neither hair-regrowth promises nor injectable use can be justified by this laboratory result alone.
No news yet for this peptide.
Hair density and growth plus skin firmness.
Information only. Not medical advice. Listing a compound is not an endorsement or a recommendation to obtain or use it. Ratings and "Our Take" are editorial opinion. Full disclaimer.